Sight is likely the most important human sense. In this context, it is well known that human neurodegenerative diseases, such as Parkinson's disease (PD) and the neuromuscular disorders called dystroglycanopathies (DGPs), cause retinal impairments and consequently vision loss (Muntoni and Voit, 2004; Bodis-Wollner, 2009 ). We have characterized the expression of PD-related genes SNCA (α-synuclein), PARK 2 (parkin) and UCHL 1 in the mammalian retina (Martínez-Navarrete et al., 2007; Esteve-Rudd et al., 2010) and have found that a number of DGP-related genes are expressed in this tissue as well (Martín-Nieto et al., 2012) . We have also described morphological (Cuenca et al., 2005) and proteomic (EsteveRudd et al., 2013) alterations taking place in the primate retina associated with parkinsonism. In this work we have attempted to catalog all known genes linked to PD and DGPs expressed in the human retina and quantify their mRNA levels. We have also focused in identifying transcript variants of these genes, in order to possibly correlate them with propensity to visual impairment.
Methods
Human retina reference RNA extracted from a pool of 29 Caucasian donors (both sexes, ages 20-60) was obtained from Clontech-BD. Total RNA was reverse-transcribed and amplified using the SMART PCR cDNA Synthesis kit (Clontech-BD). The obtained cDNA was mechanically cut into 100 bp fragments by ultrasonication, and a cDNA library was constructed using NEBNext reagents (New England Biolabs). There after, the cDNA was sequenced on an Illumina HiSeq 2000 system by Otogenetics Corp. using a read length of 100 bp, paired-end sequencing and a depth coverage of 100 million reads. Subsequent bioinformatic analyses of the obtained sequenceswere performed by Otogenetics and Genometra companies. The data processing protocol included the following computational tools:
• 
es/). • Sequence data alignment visualization:
Integrative Genome Viewer (IGV) (www.broadinstitute.org/igv/v1.4).
Results and Discussion
We have evidenced that most of the neurodegenerative disease-related genes assessed are expressed in the human retina, and their mRNA expression levels have been quantitated in terms of fragments per kilobase per million reads (FPKM) through RNA-Seq technology. These include the PD-linked genes SNCA, PARK2, UCHL1, DJ1 and PINK1, and the DGP-linked genes POMT1, POMT2, POMGNT1, FKTN (fukutin), FKRP and LARGE, among others. Besides, we have characterized the expression profile of such genes in the retina by determining their exonic, intronic and exon-intron junction expression levels. These data have allowed us to examine the alternative splicing pattern of particular genes, and as a result a number of new transcript variants have been identified. We are currently attempting to correlate particular splice variants with loss of gene function. We believe that this research should be of potential usefulness to understand the molecular bases of sight deficiencies associated with neurodegenerative disorders.
